KIF11 is a homotetrameric kinesin that peaks in protein expression during mitosis. It is a known mitotic regulator, and it is well-described that KIF11 is necessary for the formation and maintenance of the bipolar spindle. However, there has been a growing appreciation for non-mitotic roles for KIF11. KIF11 has been shown to function in such processes as axon growth and microtubule polymerization. We previously demonstrated that there is an interphase pool of KIF11 present in glioblastoma cancer stem cells that drives tumor cell invasion. Here, we identified a previously unknown association between KIF11 and primary cilia. We confirmed that KIF11 localized to the basal bodies of primary cilia in multiple cell types, including neoplastic and non-neoplastic cells. Further, we determined that KIF11 has a role in regulating cilia dynamics. Upon the reduction of KIF11 expression, the number of ciliated cells in asynchronously growing populations was significantly increased. We rescued this effect by the addition of exogenous KIF11. Lastly, we found that depleting KIF11 resulted in an increase in cilium length and an attenuation in the kinetics of cilia disassembly. These findings establish a previously unknown link between KIF11 and the dynamics of primary cilia and further support non-mitotic functions for this kinesin. KIF11, also known as Eg5 and Kinesin-5, is a mitotic kinesin that is responsible for forming and maintaining the bipolar spindle. KIF11 has primarily been studied for its mitotic role, and is thought to be mostly degraded after mitosis 1-6. However, there is a growing body of work that implicates KIF11 in other, non-mitotic cell processes. KIF11 has been demonstrated to have microtubule polymerase activity, as well as to control axon growth 7,8. It has also been shown to mediate centrosome migration after mitosis and move Golgi material 3,9. Additionally, we have previously studied a non-mitotic role for KIF11 in the context of glioblastoma (GBM). We identified that in the GBM cancer stem cell subpopulation, KIF11 is highly overexpressed throughout the cell cycle due to attenuated protein degradation 4,10. Cancer stem cells are found in many tumor types, and are characterized as being radio and chemo resistant. We found that this interphase pool of KIF11 was responsible for driving tumor cell invasion and process formation 4. In addition to these reported non-mitotic roles of KIF11, there are two patient populations that have reported mutations in the KIF11 gene. The associated diseases are known as microcephaly with or without chorioretinopathy, mental retardation, and lymphedema (MCLMR) and familial exudative vitreoretinopathy (FEVR), with the latter having reported KIF11 mutations in only a subset of the patients. The mutations are found throughout the gene, and a given mutation is not typically seen in more than one patient unless inherited 11-16. Importantly, all reported patient mutations are heterozygous, with many of the mutations predicted to lead to haploinsufficiency